BSX · News · 20260814N

Watchman Demand Slowdown

BOSTON SCIENTIFIC CORP · 2026-08-14 · Importance 20 · Surprise 24

Third-party reporting identifies slowdowns in Boston Scientific’s electrophysiology (EP) and WATCHMAN businesses as key headwinds. The report states that 74% of the company’s portfolio continues to show healthy growth, indicating that weakness is concentrated in those areas. The article characterizes the EP weakness as addressable rather than structural, but provides no quantified change in WATCHMAN demand or procedure volumes.

Key facts